A detailed history of Canada Pension Plan Investment Board transactions in Novo Cure LTD stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 13,400 shares of NVCR stock, worth $412,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,400
Previous 17,400 22.99%
Holding current value
$412,720
Previous $298,000 29.87%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.61 - $23.34 $62,440 - $93,360
-4,000 Reduced 22.99%
13,400 $209,000
Q2 2024

Aug 12, 2024

BUY
$11.83 - $24.05 $146,692 - $298,220
12,400 Added 248.0%
17,400 $298,000
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $4,452 - $6,312
400 Added 8.7%
5,000 $74,000
Q3 2023

Nov 09, 2023

BUY
$16.15 - $42.35 $74,290 - $194,810
4,600 New
4,600 $74,000
Q1 2023

May 12, 2023

BUY
$56.44 - $118.81 $1 Million - $2.11 Million
17,777 Added 1453.56%
19,000 $1.14 Million
Q4 2022

Feb 14, 2023

BUY
$63.98 - $85.37 $25,592 - $34,148
400 Added 48.6%
1,223 $89,000
Q3 2022

Nov 14, 2022

SELL
$67.99 - $89.57 $61,190 - $80,613
-900 Reduced 52.23%
823 $63,000
Q2 2022

Aug 12, 2022

BUY
$56.6 - $89.9 $97,521 - $154,897
1,723 New
1,723 $120,000
Q2 2021

Aug 16, 2021

SELL
$130.4 - $225.58 $2.02 Million - $3.5 Million
-15,520 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$124.11 - $190.17 $1.93 Million - $2.95 Million
15,520 New
15,520 $2.05 Million
Q3 2020

Nov 12, 2020

SELL
$58.05 - $111.31 $7.88 Million - $15.1 Million
-135,700 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$57.2 - $74.41 $7.76 Million - $10.1 Million
135,700 New
135,700 $8.05 Million
Q4 2018

Feb 06, 2019

SELL
$28.72 - $52.63 $3.73 Million - $6.84 Million
-130,000 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$32.0 - $52.4 $4.16 Million - $6.81 Million
130,000 New
130,000 $6.81 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.